- E-postRolf.Bjerkvig@uib.no
- Telefon+47 55 58 63 52+47 951 18 268
- BesøksadresseJonas Lies vei 915009 Bergen
- PostadressePostboks 78045020 Bergen
Rolf Bjerkvig (f. 1953) er professor for cellebiologi og har siden 80tallet jobbet i eksperimentell kreftbiologi.
I 2015 ble Bjerkvig tildelt kong Olav V kreftforskningsprisen.
- (2021). Williams Syndrome Transcription Factor (WSTF) in Brain Tumor Drug Resistance.
- (2021). TGF-β promotes microtube formation in glioblastoma through thrombospondin 1. Neuro-Oncology. 541-553.
- (2021). Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors. STAR Protocols.
- (2021). Novel thioridazine derivates: antiproliferative and apoptosis-inducing activity on glioblastoma cells in vitro get access arrow. Neuro-Oncology. vi170-vi170.
- (2021). Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1. Acta Neuropathologica. 179-189.
- (2021). Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas. Neuro-Oncology Advances (NOA).
- (2021). Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis. Neuro-Oncology Advances (NOA). 14 sider.
- (2021). A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells. Science Translational Medicine.
- (2020). Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. 1-31.
- (2020). AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications.
1987: Dr. philos. The Gade Institute of Pathology, University of Bergen
1981: M.Sc. Immunology, University of San Francisco, 1981.
Kompetansefelt